ʻO nā mea'ē aʻe i hoʻopaʻaʻia e nā amino Amino no ka hoʻopiliʻana
Huahana kikoʻipiop
| NO | Nā huahana | Kālā NO | Noi | ʻO ka hōʻailona koʻikoʻi | ||||
| ʻO Menu ka hoʻomaʻemaʻe | Isomer | ʻO ka maʻi kiko'ī | * Max1 | Kaiwa | ||||
| 1 | Fmoc-cys (acm) -oh | 86060-81-3 | Dislfide bond | ≥9s.0% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
| 2 | Fmoc-cys (mmt) -h | 177582-21-7 | Dislfide bond | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 3 | FMC-CYS (4-Allylbutyray) -H | / | Dislfide bond | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 4 | Mpa (srt) -oh | 27144-18-9 | Ka hopena o ka pauku | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
| 5 | Fmoc-th (tbu) -OL | 189337-28-8 | Occreide | ≥90.0% | ≤0.3% | ≤0.5% | ≤1.0% | ≤1.0% |
| 6 | Fmoc-d-arg (pbf) -oh | 187618-60-6 | FIIShodyK | ≥9s.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤2.0% |
| 7 | Fmoc-gly-gly-oh | 35665-38-4 | Pilihianh | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
| 8 | Fmoc-gly-gly-gly-oh | 170941-79-4 | KaukaMākaʻi | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
| 9 | FMO-Gly-Gly-Gly-Oh | / | Pilihianh | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
| 10 | FMOC-Gly-ASP (TBU) -HH | / | Pilihianh | ≥99.5% | / | ≤0.15% | ≤0.2% | ≤1.0% |
| 11 | BOC-CYS (TRT) -HH | 21947-98-8 | Ka hopena o ka pauku | ≥9s.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 12 | Boc-arg (pbf) -oh | 200124-22-7 | Ka hopena o ka pauku | ≥9s.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 13 | Boc-ala-oh | 15761-38-3 | Ka hopena o ka pauku | ≥9s.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 14 | Boc-d-phe-oh | 18942-49-9 | Ka hopena o ka pauku | ≥9s.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 15 | Boc-gly-oh | 4530-20-5 | Ka hopena o ka pauku | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
| 16 | Boc-lys (boc) -oh.dcha | 15098-69-8 | Ka hopena o ka pauku | ≥9s.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 17 | Boc-ser (tbu) -oh | 7738-22-9 | Ka hopena o ka pauku | ≥9s.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 18 | Boc-th (tbu) -oh | 13734-40-2 | Ka hopena o ka pauku | ≥9s.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 19 | Boc-D-ala-Oh | 7764-95-6 | Ka hopena o ka pauku | ≥9s.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 20 | Boc-my-oh | 2488-15-5 | Ka hopena o ka pauku | ≥9s.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 21 | Boc-tyr (tbu) -oh | 47375-34-8 | Ka hopena o ka pauku | ≥9s.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 22 | Boc-d-arg (pdf) -oh | 187618-60-6 | Ka hopena o ka pauku | ≥9s.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 23 | Boc-asp (Otbu) -oh.dcha | 193/12/8 | Ka hopena o ka pauku | ≥9s.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 24 | FMOC-HOMOR-HOMF) -Oh | 1159680-21-3 | Eppicibaride | ≥98.5% | ≤0.2% | / | ≤0.5% | ≤2.0% |
| 25 | FMOC-ASP-OTBU | 129460-09-9 | Kāu meaʻole | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
| 26 | Fmoc-tyr (me) -oh | 77128-72-4 | Kaʻaikini | ≥98.5% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 27 | Fmoc-orn (boc) -oh | 109425-55-0 | Aosiban OmnipressUn Like gptonycin | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤2.0% |
| 28 | FMOC-D-Tyr (et) -oh | 162502-65-0 | Aosiban | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
| 29 | Fmoc-asp (oall) -oh | 146982-24-3 | Meahana Melanothaan | ≥9s.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 30 | AC-NLE-OH | 15891-49-3 | Meahana Melanothaan | ≥9s.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
| 31 | FMC-NLE-OH | 77284-32-3 | Meahana Melanothaan Avefallanode | ≥9s.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
| 32 | Ac-glu (otbu) -oh | 84192-88-1 | Hāʻawi Kekahi Actatsl octapeptide-3 | ≥9s.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 33 | AC-Β-ala-Ohr · DCHA | / | Acetyl verrapeptide-5 | ≥9s.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
| 34 | Fmoc-ß - ala-oh | 35737-10-1 | Acetyl verrapeptide-5 | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
| 35 | FMOC-HYP (TBU) -HH | 122996-47-8 | ICATIBANT | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 36 | Fmoc-thi-oh | 130309-35-2 | ICATIBANT | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 37 | FMOC-D-TIC-OH | 130309-33-0 | ICATIBANT | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 38 | Fcoc-ooc-oh | 130309-37-4 | ICATIBANT | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 39 | Boc-sar-Oh | 13734-36-6 | Saralasin | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 40 | FMC-SAR-OH | 77128-70-2 | Saralasin | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 41 | FMOC-TYR (SO3NA) -OH2O | 106864-37-3 | Hawaiinzede | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 42 | FMOC-D-ASP (OTBU) -Oh | 112883-39-3 | Like gptonycin | ≥98.5% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 43 | Ac-ser (tbu) -oh | 77285-09-7 | Avefallanode | ≥9s.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 44 | Boc-homocys (trt) -oh | 201419-16-1 | Hoʻowahāwahā | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 45 | FMOC-Homocs (Trt) -H | 16015-23-8 | Hoʻowahāwahā | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 46 | Fmc-dab-Oh | 161420-87-7 | Snake venom | ≥9s.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
* Max1 = Max Unoʻeliʻiʻikeʻike
ʻO nā kuhikuhi'ē aʻe:
- ACETIC ACID: ≤0.02% (nā huahana āpau)
- Etyl Acetate: ≤0.5% (nā huahana āpau)
- OMERIL: ≤0.5% (nā huahana āpau)
- Max Vismornon Infaght: FMOC-TRP-TRP (BOC) -HH (143824-78-6) ≤0.3-6) ≤0.3 I kekahi ≤0.2%
